We then employed HLA-restricted humanized mice as a pre-clinical model to assess the efficacy of LD IL-2 in IBD and found that LD IL-2 expanded human Treg cells and was protective against experimental colitis (28). The gene discussed is IL2; the disease is inflammatory bowel disease.